Sterling Pharma Solutions
Vagn Pedersen is an experienced supply chain professional with a career spanning over two decades in various leadership roles. Currently serving as Associate Director of Supply Chain at Sterling Pharma Solutions since September 2020, Vagn previously held the position of Associate Director of Supply Chain at Alcami Corporation from May 2019 to September 2020, where Vagn also served as Sr. Manager of Supply Chain & Logistics. Earlier experience includes managing supply chain, procurement, and logistics at Alcami (AAIPharma Services Corp./Cambridge Major Laboratories Inc.) from June 2010 to April 2019, and serving as Director of Supply Chain at DAKO from November 2006 to August 2009. Vagn's career began at Chr. Hansen Inc., where roles included Supply Chain Manager, Planning and Inventory Control Manager, and Project Manager between May 2005 and April 2005. Vagn holds a degree from Copenhagen Business School, earned between 1989 and 1995.
This person is not in any teams
This person is not in any offices
Sterling Pharma Solutions
1 followers
Sterling Pharma Solutions has over 50 years' experience serving the global pharmaceutical industry. Our facilities are located in Cramlington and Newcastle Biosphere, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Our state-of-the-art facilities, proprietary technologies and experienced people are among the best in the industry. We have a proven track record in the supply of chemistry and analytical services across the entire product lifecycle, from grams to tonnes, from pre-clinical to commercial supply. Our world-class safety and quality standards are globally recognised and demonstrated through successful MHRA and FDA inspections and CIA Gold Awards for Safety the last three consecutive years. We pride ourselves on our customer focus and service approach, offering flexible, tailored solutions to our customers. In addition, our North Carolina and Newcastle Biosphere facilities offer expert chemistry solutions for small volume batches or products in the early stages of clinical trials. Our Deeside, Wales facility provide bioconjugation development services and specialised in antibody drug conjugation (ADC) research and development. Find out more: www.sterlingpharmasolutions.com/sterling-facilities